# Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia

> **NCT00723073** · — · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 323 (actual)

## Conditions studied

- Febrile Neutropenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00723073
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2010-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00723073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00723073, "Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00723073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*